| 中山醫學大學 |
2020 |
Survival Analysis of Pathological T3a Upstaging in Clinical T1 Renal Cell Carcinoma
|
Lai, GS; Li, JR; Wang, SS; Chen, CS; Yang, CK; Hung, SC; Cheng, CL; Ou, YC; Chiu, KY |
| 中國醫藥大學 |
2007-11-02 |
Survival analysis of pediatric dialysis patients from Taiwan
|
黃秋錦(Chiu-Ching Huang); 吳宏達(Hong-Dar Issac Wu); 林清淵; 陳永銘(Yung-ming Chen) |
| 中國醫藥大學 |
2012-09 |
Survival analysis of pediatric dialysis patients in Taiwan
|
林信宏(Hsin-Hung Lin);蔡靜瑋(CHING-WEI TSAI);林保萱(PAO-HSUAN LIN);鄭光甫(Kuang-Fu Cheng);吳宏達(Hong-Dar Isaac Wu);王怡寬(I-Kuan Wang);林清淵(Ching-Yuang Lin);陳偉德(Walter Chen);黃秋錦(Chiu-Ching Huang)* |
| 中國醫藥大學 |
2015-10 |
Survival analysis of the use of first and second generation antipsychotics among patients suffering schizophrenia: A nationwide population-based cohort study
|
(Chen VC);(Liao YT);(Lai TJ);藍先元(Hsien-Yuan Lane);(Shao WC);(Dewey M);(Lee CT);(Lu ML)* |
| 中國醫藥大學 |
2005-05-27 |
Survival and AIDS Incidence in Taiwan Before and After Introduction of Combination ART.
|
李采娟(Tsai-Chung Li); (Ying-Hen Hsieh); 涂醒哲(Shiing-Jer Twu); (Hsu-Mei Hsu); 林正介(Cheng-Chieh Lin) |
| 國立臺灣大學 |
2014 |
Survival and developmental milestones among Pompe registry patients with classic infantile-onset Pompe disease with different timing of initiation of treatment with enzyme replacement therapy (ERT)
|
Chien, Yin-Hsiu; van der Ploeg, Ans; Jones, Simon A.; Byrne, Barry; Vellodi, Ashok; Leslie, Nancy; Mengel, Eugen; Shankar, Suma; Tanpaiboon, Pranoot; Stockton, David W.; Hennermann, Julia B.; Devecseri, Zsuzsanna; Kempf, Judy; Keutzer, Joan; Kishnani, Priya S.; 簡穎秀 |
| 臺大學術典藏 |
2020-12-24T06:16:13Z |
Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
|
Lin H.-Y.; Lee C.-L.; Chang C.-Y.; Chiu P.C.; YIN-HSIU CHIEN; Niu D.-M.; Tsai F.-J.; Hwu W.-L.; Lin S.J.; Lin J.-L.; Chao M.-C.; Chang T.-M.; Tsai W.-H.; Wang T.-J.; Chuang C.-K.; Lin S.-P. |
| 臺大學術典藏 |
2021-06-09T08:12:18Z |
Survival and diagnostic age of 175 Taiwanese patients with mucopolysaccharidoses (1985–2019)
|
Lin H.-Y.;Lee C.-L.;Chang C.-Y.;Chiu P.C.;Chien Y.-H.;Niu D.-M.;Tsai F.-J.;Wuh-Liang Hwu;Lin S.J.;Lin J.-L.;Chao M.-C.;Chang T.-M.;Tsai W.-H.;Wang T.-J.;Chuang C.-K.;Lin S.-P.; Lin H.-Y.; Lee C.-L.; Chang C.-Y.; Chiu P.C.; Chien Y.-H.; Niu D.-M.; Tsai F.-J.; WUH-LIANG HWU; Lin S.J.; Lin J.-L.; Chao M.-C.; Chang T.-M.; Tsai W.-H.; Wang T.-J.; Chuang C.-K.; Lin S.-P. |
| 亞洲大學 |
2009 |
Survival and Hospitalization Among Dialysis Patients In Taiwan In 2001-2005:Propensity Score Approach
|
Fenni Widya Sari |
| 國立臺灣大學 |
1995-07 |
Survival and interim endpoints in breast cancer
|
Day, NE; Duffy, SW; Chen, THH |
| 亞洲大學 |
2017-06 |
Survival and medical utilization of children and adolescents with prolonged ventilator-dependent and associated factors
|
柏斯琪;SC, Pai;龔佩珍;Kung, Pei-Tseng;周文鈺;WY, Chou;Kuo, T;Kuo, T;蔡文正;WC, Tsai |
| 中山醫學大學 |
2021 |
Survival and Treatment of Lung Cancer in Taiwan between 2010 and 2016
|
Chang, YJ; Huang, JY; Lin, CH; Wang, BY |
| 臺大學術典藏 |
2022-03-31T02:38:38Z |
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
|
Chuang M.-C.; Yang Y.-H.; Tsai Y.-H.; Hsieh M.-J.; Lin Y.-C.; Lin C.-K.; PAU-CHUNG CHEN; Yang T.-M. |
| 國立成功大學 |
2021 |
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
|
Su, P.-L.;Tsai, J.-S.;Yang, S.-C.;Wu, Y.-L.;Tseng, Y.-L.;Chang, Chang C.-C.;Yen, Yen Y.-T.;Lin, C.-Y.;Lin, C.-C.;Wang, C.-C.;Lin, M.-C.;Su, W.-C. |
| 國立成功大學 |
2021-08 |
Survival benefit of osimertinib combination therapy in patients with T790M-positive non-small-cell lung cancer refractory to osimertinib treatment
|
林建中; Lin, Chien-Chung; Su, Po-Lan;Tsai, Jeng-Shiuan;Yang, Szu-Chun;Wu, Yi-Lin;Tseng, Yau-Li;Chang, Chao-Chun;Yen, Yi-Ting;Lin, Chia-Ying;Wang, Chin-Chou;Lin, Meng-Chih;Su, Wu-Chou |
| 臺大學術典藏 |
2019-03-04T02:57:00Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
CHIANG,CHUN-JU; CHIANG,CHUN-JU |
| 臺大學術典藏 |
2020-02-06T05:21:51Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
WEN-FANG CHENG;Tang C.-H.;Hsieh S.-F.;You S.-L.;Chen Y.-Y.;Chiang C.-J.;Chen C.-A.; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG; Chen C.-A.; Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG |
| 臺大學術典藏 |
2020-02-14T02:49:41Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
Chiang C.-J.; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; WEN-FANG CHENG; Chen C.-A.;Chiang C.-J.;Chen Y.-Y.;You S.-L.;Hsieh S.-F.;Tang C.-H.;Wen-Fang Cheng; Chen C.-A. |
| 臺大學術典藏 |
2021-05-07T06:02:23Z |
Survival benefit of patients with early-stage ovarian carcinoma treated with paclitaxel chemotherapeutic regimens
|
Chen C.-A.;Chun-Ju Chiang;Chen Y.-Y.;You S.-L.;Hsieh S.-F.;Tang C.-H.;Cheng W.-F.; Chen C.-A.; CHUN-JU CHIANG; Chen Y.-Y.; You S.-L.; Hsieh S.-F.; Tang C.-H.; Cheng W.-F. |
| 臺北醫學大學 |
2012 |
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients
|
LH, Yang;HS, Tseng;Lin, C;LS, Chen;ST, Chen;SJ, Kuo;DR, Chen |
| 臺北醫學大學 |
2012 |
Survival benefit of tamoxifen in estrogen receptor-negative and progesterone receptor-positive low grade breast cancer patients
|
Yang, LH;Tseng, HS;Lin, C;Chen, LS;Chen, ST;Kuo, SJ;Chen, DR |
| 國立臺灣大學 |
2006 |
Survival Benefit of Transcatheter Arterial Chemoembolization in Patients with Hepatocellular Carcinoma Larger Than 10 Cm in Diameter
|
黃怡翔; 吳肇卿; 陳信成; 陳健弘; 李壽東; HUANG; YI-HSIANG; WU, JAW-CHING; CHEN, SHINN-CHERNG; CHEN, CHIEN-HUNG; LEE, SHOU-DONG |
| 臺大學術典藏 |
2022-02-22T05:34:33Z |
Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter
|
Huang Y.-H.; Wu J.-C.; Chen S.-C.; CHIEN-HUNG CHEN; Chiang J.-H.; Huo T.-I.; Lee P.-C.; Chang F.-Y.; Lee S.-D. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter
|
Huang Y.-H.; Wu J.-C.; Chen S.-C.; CHIEN-HUNG CHEN; Chiang J.-H.; Huo T.-I.; Lee P.-C.; Chang F.-Y.; Lee S.-D. |
| 臺大學術典藏 |
2021-01-12T12:49:01Z |
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
|
Martinez G.; de Queiroz Crusoe E.; Maiolino A.; Lee J.H.; Hungria V.T.M.; Bittencourt R.; Duarte G.O.; Fantl D.B.; Navarro J.R.; Conte G.; Gomez-Almaguer D.; Ruiz-Argüelles G.J.; Kim K.; Shimizu K.; Chen W.; SHANG-YI HUANG; Chng W.-J.; Chim C.S.; Nawarawong W.; Durie B. |
